STRATA Skin Sciences to Present at the Lytham Partners Spring 2021 Investor Conference
STRATA Skin Sciences, a leader in dermatology tech, announced its participation in the Lytham Partners Spring 2021 Investor Conference on March 30 at 3:30 p.m. ET. The event will include management presentations and virtual one-on-one meetings from March 30 to April 1, 2021. Interested parties can access the presentation via the company's website. STRATA specializes in innovative products for dermatologic conditions, including the XTRAC® excimer laser. With over 832 partner clinics and a global device base exceeding 2,300, STRATA aims to revolutionize skin disease treatment.
- None.
- None.
HORSHAM, Pa., March 16, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA”) (NASDAQ: SSKN), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that the company will participate in the upcoming Lytham Partners Spring 2021 Investor Conference.
STRATA Skin’s management is scheduled to present on Tuesday, March 30, 2021, at 3:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at www.strataskinsciences.com. Management will also participate in virtual one-on-one meetings throughout the event, which runs from March 30 through April 1, 2021. To request a meeting, please contact Lytham Partners at 1x1@lythampartners.com, or register at www.lythampartners.com/spring2021reg.
About STRATA Skin Sciences, Inc.
STRATA Skin Sciences is a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions. Its products include the XTRAC® excimer laser and VTRAC® lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions.
The Company’s proprietary XTRAC® excimer laser delivers a highly targeted therapeutic beam of UVB light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma, diseases which impact over 31 million patients in the United States alone. The technology is covered by multiple patents, including exclusive rights for patents for the delivery of treatment to vitiligo patients.
STRATA’s unique business model leverages targeted Direct to Consumer (DTC) advertising to generate awareness and utilizes its in-house call center and insurance advocacy teams to increase volume for the Company’s partner dermatology clinics.
The XTRAC business has used this proven DTC model to grow its domestic dermatology partner network to over 832 clinics, with a worldwide installed base of over 2,300 devices. The Company is able to offer
The Company has now introduced its Home by XTRAC™ business, leveraging in-house resources; including DTC advertising, in-house call center and its insurance reimbursement team to provide an at-home, insurance-reimbursed treatment option for patients with certain skin diseases that do not qualify for in-office treatments.
Investor Contacts:
| Leigh Salvo | ||
| (415) 937-5404 | ||
| ir@strataskin.com |
FAQ
When will STRATA Skin Sciences present at the Lytham Partners Spring 2021 Investor Conference?
How can I access STRATA Skin Sciences' presentation during the investor conference?
What technology does STRATA Skin Sciences focus on for treating skin conditions?
How many clinics are partnered with STRATA Skin Sciences for their dermatology products?
What is the significance of March 30 to April 1, 2021, for STRATA Skin Sciences?
